T-cell activation and maturation at tumor site associated with objective response to ipilimumab in metastatic melanoma

J Clin Oncol. 2011 Nov 10;29(32):e783-8. doi: 10.1200/JCO.2011.36.5957. Epub 2011 Oct 11.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • CTLA-4 Antigen / antagonists & inhibitors
  • Humans
  • Ipilimumab
  • Lymphocyte Activation*
  • Male
  • Melanoma / drug therapy*
  • Melanoma / immunology
  • Melanoma / mortality
  • Melanoma / secondary
  • T-Lymphocytes / immunology*
  • Tomography, X-Ray Computed

Substances

  • Antibodies, Monoclonal
  • CTLA-4 Antigen
  • Ipilimumab